Why BrainChip, Coles, Fisher & Paykel Healthcare, and PolyNovo shares are rising


The S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and is sinking deep into the red on Friday. In afternoon trade, the benchmark index is down 2.3% to 7,194.1 points.

Four ASX shares that have defied the selloff and pushed higher are listed below. Here’s why they are rising:

Brainchip Holdings Ltd (ASX: BRN)

The Brainchip share price is up 3% to $1.06. The artificial intelligence technology company’s shares were up as much as 18% at one stage. This resulted in the company being hit with a price query from the Australian stock exchange. BrainChip advised that it could not explain the rise and its shares quickly gave back the majority of their earlier gains.

The Coles share price is up 1.5% to $18.75. This appears to have been driven by demand for defensive shares amid the market selloff. As a supermarket operator, Coles is seen as a good hedge against rising inflation.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

The Fisher & Paykel Healthcare share price is up over 2% to $19.84. This is despite there being no news out of the medical device company. However, the company’s shares were trading at a two-year low earlier this week. Some investors may believe this has created a buying opportunity.

The PolyNovo share price is up 4.5% to 90.5 cents. Investors have been buying this medical device company’s shares after it revealed that insiders have been buying shares. One of those was PolyNovo’s chairman, David Williams. He picked up 500,000 shares through an on-market trade on Thursday. Mr Williams paid an average of $0.8689 per share, which represents a total consideration of $434,450.

Source: Read More

We’ve Already Come Too Far To End This Now.

Subscribe To Our Weekly Newsletter

Get notified about new articles